Transarterial chemoembolization with or without multikinase inhibitors for patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Randomized controlled trials (RCTs) testing the combination therapy of transarterial chemoembolization (TACE) plus multikinase inhibitor (MKI) in patients with unresectable hepatocellular carcinoma (HCC) have yielded inconsistent results. METHODS: In this work, a systematic review and me...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Han, Ge, Dongfang, Qu, Biao, Zhu, Ping, Wu, Qibiao, Wang, Tianyun, Wang, Jue, Li, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285094/
https://www.ncbi.nlm.nih.gov/pubmed/37361570
http://dx.doi.org/10.3389/fonc.2023.1139025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285094/
https://www.ncbi.nlm.nih.gov/pubmed/37361570
http://dx.doi.org/10.3389/fonc.2023.1139025

Ejemplares similares